Delivery Order SPE2DB22D2206-SPE2DB24FGV63
Award Date
4/23/24
Potential Completion Date
4/24/24
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of OLOPATADINE HCL 0.1% EYE DROPS 5ML. The firm-fixed-price delivery order, valued at $1,115.33, has a completion date of November 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical as a primary vehicle for providing a wide range of pharmaceutical products and medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Olopatadine Hydrochloride 0.1% eye drops. The $2,112.82 firm-fixed-price contract has a performance period through May 2025 and is not set aside. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through...
This federal contract award, valued at $2,115.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Olopatadine Hydrochloride 0.1% eye drops, a specialty medication, to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order with a completion date of March 12, 2025. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $1,825.66 firm fixed price delivery order is for the supply of Olopatadine HCL 0.1% eye drops, a prescription ophthalmic medication. The contract has a period of performance through March 20, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor on an...
This federal contract award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp is a Delivery Order valued at $1,009.00 for the procurement of Olopatadine HCl 0.1% eye drops in 5 ml containers. The contract has an ultimate completion date of October 31, 2023 and is a Firm Fixed Price agreement. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is the prime contractor for this award, which is not designated as a set-aside contract....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award has a contract value of $1,162.44 and is for the delivery of OLOPATADINE HCL 0.1% EYE DROPS 5ML. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the delivery of Olopatadine Hydrochloride 0.1% Eye Drops in 5 mL containers. The award, with a ceiling value of $2,085.00, is a Firm Fixed Price Delivery Order contract with a completion date of August 2, 2024. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp.'s Corporate Office Division is the prime contractor for this award, which is part...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,382.67 firm fixed-price delivery order is for the supply of OLOPATADINE 0.1% OS 1S, a prescription eye drop medication. The contract has an ultimate completion date of April 18, 2025 and was awarded on March 24, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a...
This federal contract award, valued at $3,476.43, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract provides for the delivery of OLOPATADINE HCL 0.1% eye drops with an ultimate completion date of February 15, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued at up to $999,999,999.00, and the...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,308.39, is for the delivery of OLOPATADINE HCL 0.1% eye drops in 5ml quantities. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for...